Progress in risk assessment and management: Forecasting updates across international cholesterol guidelines
Open Access
- 10 January 2026
- journal article
- review article
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 26, 101417
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery DiseaseJAMA, 2025
- Role of Aspirin in Reducing Risk for Atherosclerotic Cardiovascular Disease in Individuals with Elevated Lipoprotein(a)Current Atherosclerosis Reports, 2025
- Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial InfarctionJAMA Cardiology, 2024
- Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk EquationsJAMA, 2024
- The Evolving Landscape of Cardiovascular Risk AssessmentJAMA, 2024
- Atorvastatin for Anthracycline-Associated Cardiac DysfunctionJAMA, 2023
- Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant PatientsJAMA, 2023
- Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018JAMA, 2022
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular DiseaseJAMA, 2019